Intellia Therapeutics
NTLA
#4904
Rank
A$2.23 B
Marketcap
$21.99
Share price
3.62%
Change (1 day)
-53.52%
Change (1 year)

Intellia Therapeutics (NTLA) Fails to deliver data

Key failure to deliver metrics for Intellia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intellia Therapeutics (NTLA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intellia Therapeutics (NTLA) - since 2016

Volume in USD (price x number of shares), data since 2016

Intellia Therapeutics (NTLA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$15.41 M220.46%
2023A$4.81 M-74.6%
2022A$18.94 M-78.06%
2021A$86.32 M59.26%
2020A$54.2 M91.14%
2019A$28.35 M-26.57%
2018A$38.61 M258.03%
2017A$10.78 M16.86%
2016A$9.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1.5 MA$5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA